David Richards

David V. Richards is a life sciences executive with distinct expertise in corporate development, capital structuring, research and development, program management and intellectual property development. Mr. Richards currently serves as Chief Executive Officer for Clarametyx Biosciences, Inc., which is developing a transformational immune-enabling biologic platform of bacterial biofilm structure-targeting therapies and vaccines. Previously, Mr. Richards served in operational and general counsel roles for Aclipse Therapeutics, N8 Biosciences and PriorAuthNow, Inc.